Actively Recruiting
InTake Care: Development and Validation of an Innovative, Personalized Digital Health Solution for Medication Adherence Support in Cardiovascular Prevention
Led by Istituto Auxologico Italiano · Updated on 2025-08-21
206
Participants Needed
1
Research Sites
78 weeks
Total Duration
On this page
Sponsors
I
Istituto Auxologico Italiano
Lead Sponsor
I
Istituti Clinici Scientifici Maugeri SpA
Collaborating Sponsor
AI-Summary
What this Trial Is About
Inadequate medication adherence (MA) in chronic conditions, including cardiovascular prevention, represents an important risk factor. The use of new IT technologies in this setting is supposed to be useful to improve patients' adherence, but currently available solutions have significant limitations, including lack of personalization and reliance on expensive ad hoc systems. This interdisciplinary project aims to verify the hypothesis that in patients on chronic antihypertensive treatment MA can be improved through the implementation of a novel digital health solution for MA monitoring and support, based on inexpensive and user-friendly, commercially available technology (voice assistant), connected with web interface for the physician. The intervention will be personalized based on the creation of Personas, intended as multidisciplinary-based representations of different user types. This approach will be tested in a randomized clinical trial.
CONDITIONS
Official Title
InTake Care: Development and Validation of an Innovative, Personalized Digital Health Solution for Medication Adherence Support in Cardiovascular Prevention
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult (>18 years old) patients
- History of essential hypertension
- Treatment with at least one antihypertensive drug with available plasma assay
- Wireless internet connection available at patient's home
- Stable clinical conditions
- Written informed consent
You will not qualify if you...
- Insufficient technological literacy to manage vocal assistant
- Dementia or significant psychiatric disorders
- Conditions limiting vocal communication (deafness, significant speech disorders, poor knowledge of Italian)
- Pregnancy or breastfeeding
- Active cancer (except basal cell skin carcinoma)
- Upper limb amputation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
San Luca Hospital, Istituto Auxologico Italiano IRCCS
Milan, Italy, 20149
Actively Recruiting
Research Team
G
Grzegorz Bilo, MD, PhD
CONTACT
L
Lucia Zanotti, Bsc, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here